| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aging | 70 | 2025 | 680 | 8.370 |
Why?
|
| Cognition Disorders | 66 | 2019 | 437 | 7.320 |
Why?
|
| Alzheimer Disease | 69 | 2025 | 800 | 6.150 |
Why?
|
| Cognition | 66 | 2023 | 641 | 5.850 |
Why?
|
| Cognitive Dysfunction | 39 | 2025 | 449 | 5.710 |
Why?
|
| Aged | 168 | 2025 | 4000 | 4.220 |
Why?
|
| Aged, 80 and over | 134 | 2025 | 2152 | 4.160 |
Why?
|
| Longitudinal Studies | 78 | 2025 | 651 | 3.820 |
Why?
|
| Male | 170 | 2025 | 6815 | 3.410 |
Why?
|
| Female | 171 | 2025 | 6974 | 3.400 |
Why?
|
| Brain | 35 | 2023 | 707 | 3.390 |
Why?
|
| Dementia | 21 | 2021 | 236 | 3.320 |
Why?
|
| Humans | 189 | 2025 | 12240 | 2.850 |
Why?
|
| Neuropsychological Tests | 56 | 2022 | 558 | 2.690 |
Why?
|
| Lewy Bodies | 9 | 2021 | 96 | 2.370 |
Why?
|
| Olfaction Disorders | 6 | 2021 | 24 | 2.280 |
Why?
|
| Memory, Episodic | 6 | 2022 | 43 | 1.650 |
Why?
|
| DNA-Binding Proteins | 8 | 2019 | 151 | 1.410 |
Why?
|
| Depression | 13 | 2016 | 229 | 1.380 |
Why?
|
| Cohort Studies | 36 | 2024 | 827 | 1.380 |
Why?
|
| Neurodegenerative Diseases | 5 | 2021 | 60 | 1.370 |
Why?
|
| Disease Progression | 19 | 2019 | 290 | 1.260 |
Why?
|
| Independent Living | 12 | 2025 | 137 | 1.170 |
Why?
|
| Interpersonal Relations | 7 | 2014 | 48 | 1.170 |
Why?
|
| Memory | 13 | 2016 | 112 | 1.160 |
Why?
|
| Apolipoprotein E4 | 14 | 2025 | 106 | 1.140 |
Why?
|
| Loneliness | 8 | 2025 | 31 | 1.140 |
Why?
|
| Risk Factors | 42 | 2021 | 1049 | 1.090 |
Why?
|
| Chicago | 27 | 2025 | 453 | 1.090 |
Why?
|
| Hospitalization | 4 | 2019 | 158 | 1.080 |
Why?
|
| Educational Status | 18 | 2022 | 130 | 1.040 |
Why?
|
| Lewy Body Disease | 4 | 2021 | 54 | 1.030 |
Why?
|
| Cognitive Aging | 5 | 2018 | 34 | 1.010 |
Why?
|
| Follow-Up Studies | 26 | 2019 | 726 | 0.980 |
Why?
|
| Middle Aged | 31 | 2021 | 4043 | 0.940 |
Why?
|
| Hippocampus | 5 | 2022 | 97 | 0.890 |
Why?
|
| Geriatric Assessment | 18 | 2017 | 96 | 0.850 |
Why?
|
| Apolipoproteins E | 13 | 2023 | 100 | 0.850 |
Why?
|
| Health Literacy | 4 | 2019 | 45 | 0.840 |
Why?
|
| Substantia Nigra | 4 | 2021 | 68 | 0.840 |
Why?
|
| Motor Activity | 12 | 2015 | 175 | 0.840 |
Why?
|
| Stress, Psychological | 7 | 2021 | 112 | 0.840 |
Why?
|
| Memory, Short-Term | 4 | 2019 | 53 | 0.830 |
Why?
|
| Parkinsonian Disorders | 7 | 2019 | 91 | 0.830 |
Why?
|
| Decision Making | 8 | 2022 | 95 | 0.820 |
Why?
|
| Perception | 4 | 2021 | 42 | 0.800 |
Why?
|
| Memory Disorders | 5 | 2019 | 68 | 0.790 |
Why?
|
| Autopsy | 12 | 2021 | 174 | 0.780 |
Why?
|
| Cerebral Cortex | 2 | 2021 | 77 | 0.760 |
Why?
|
| Activities of Daily Living | 14 | 2013 | 182 | 0.730 |
Why?
|
| Personality | 3 | 2015 | 18 | 0.730 |
Why?
|
| Age of Onset | 3 | 2021 | 46 | 0.720 |
Why?
|
| Life Style | 4 | 2021 | 102 | 0.700 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2017 | 182 | 0.680 |
Why?
|
| Amygdala | 1 | 2021 | 14 | 0.680 |
Why?
|
| Amyloid beta-Peptides | 5 | 2023 | 98 | 0.670 |
Why?
|
| Neurofibrillary Tangles | 5 | 2017 | 64 | 0.670 |
Why?
|
| Age Factors | 15 | 2019 | 350 | 0.660 |
Why?
|
| Olfactory Bulb | 1 | 2019 | 7 | 0.600 |
Why?
|
| Neocortex | 1 | 2019 | 17 | 0.600 |
Why?
|
| United States | 18 | 2021 | 989 | 0.600 |
Why?
|
| Mortality | 5 | 2016 | 37 | 0.590 |
Why?
|
| Language | 2 | 2010 | 30 | 0.560 |
Why?
|
| Proportional Hazards Models | 17 | 2017 | 161 | 0.560 |
Why?
|
| Death | 4 | 2021 | 24 | 0.550 |
Why?
|
| Prospective Studies | 23 | 2025 | 817 | 0.550 |
Why?
|
| Anxiety Disorders | 2 | 2016 | 84 | 0.540 |
Why?
|
| Learning | 1 | 2018 | 34 | 0.530 |
Why?
|
| Chronic Disease | 3 | 2017 | 186 | 0.530 |
Why?
|
| Neurons | 3 | 2013 | 164 | 0.520 |
Why?
|
| Reading | 2 | 2021 | 12 | 0.520 |
Why?
|
| Ambulatory Care | 1 | 2017 | 36 | 0.510 |
Why?
|
| Nervous System Diseases | 2 | 2018 | 60 | 0.500 |
Why?
|
| Agnosia | 1 | 2016 | 3 | 0.490 |
Why?
|
| Brain Chemistry | 1 | 2016 | 22 | 0.470 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 55 | 0.460 |
Why?
|
| Urban Population | 3 | 2013 | 78 | 0.460 |
Why?
|
| Motor Skills | 2 | 2013 | 32 | 0.450 |
Why?
|
| Risk | 14 | 2018 | 97 | 0.450 |
Why?
|
| Longevity | 2 | 2013 | 15 | 0.450 |
Why?
|
| Severity of Illness Index | 11 | 2021 | 423 | 0.440 |
Why?
|
| Research Design | 3 | 2020 | 79 | 0.410 |
Why?
|
| Incidence | 16 | 2025 | 338 | 0.410 |
Why?
|
| Mesencephalon | 1 | 2013 | 13 | 0.400 |
Why?
|
| Exercise | 4 | 2022 | 233 | 0.400 |
Why?
|
| Odorants | 2 | 2010 | 7 | 0.400 |
Why?
|
| Disabled Persons | 5 | 2013 | 47 | 0.390 |
Why?
|
| Membrane Transport Proteins | 3 | 2017 | 33 | 0.380 |
Why?
|
| Delivery of Health Care | 4 | 2022 | 62 | 0.360 |
Why?
|
| Family | 3 | 2021 | 52 | 0.350 |
Why?
|
| Cross-Sectional Studies | 10 | 2022 | 400 | 0.350 |
Why?
|
| Diet | 4 | 2010 | 104 | 0.340 |
Why?
|
| Sclerosis | 4 | 2020 | 32 | 0.330 |
Why?
|
| Mobility Limitation | 5 | 2015 | 36 | 0.330 |
Why?
|
| Frail Elderly | 4 | 2014 | 19 | 0.330 |
Why?
|
| Knowledge | 1 | 2010 | 7 | 0.320 |
Why?
|
| Mental Status and Dementia Tests | 5 | 2023 | 36 | 0.320 |
Why?
|
| Surveys and Questionnaires | 10 | 2020 | 546 | 0.310 |
Why?
|
| Tissue Donors | 2 | 2020 | 42 | 0.310 |
Why?
|
| Social Isolation | 3 | 2025 | 15 | 0.310 |
Why?
|
| Time Factors | 10 | 2020 | 695 | 0.310 |
Why?
|
| Psychomotor Performance | 4 | 2019 | 85 | 0.310 |
Why?
|
| Stroke | 3 | 2016 | 117 | 0.310 |
Why?
|
| Plaque, Amyloid | 4 | 2017 | 45 | 0.300 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2015 | 57 | 0.300 |
Why?
|
| Genotype | 12 | 2018 | 169 | 0.300 |
Why?
|
| Disability Evaluation | 9 | 2015 | 105 | 0.290 |
Why?
|
| Sex Factors | 8 | 2018 | 229 | 0.290 |
Why?
|
| Literacy | 2 | 2021 | 13 | 0.290 |
Why?
|
| Social Support | 4 | 2014 | 98 | 0.290 |
Why?
|
| Parkinson Disease | 5 | 2017 | 314 | 0.280 |
Why?
|
| Antioxidants | 3 | 2005 | 34 | 0.280 |
Why?
|
| Models, Psychological | 5 | 2015 | 37 | 0.280 |
Why?
|
| Social Class | 2 | 2005 | 24 | 0.270 |
Why?
|
| Mental Recall | 2 | 2020 | 24 | 0.270 |
Why?
|
| Feeding Behavior | 2 | 2005 | 40 | 0.270 |
Why?
|
| Alleles | 9 | 2023 | 119 | 0.270 |
Why?
|
| Language Tests | 2 | 2013 | 16 | 0.270 |
Why?
|
| Reaction Time | 2 | 2020 | 53 | 0.260 |
Why?
|
| Biomarkers | 4 | 2023 | 294 | 0.260 |
Why?
|
| Neurologic Examination | 2 | 2020 | 49 | 0.250 |
Why?
|
| Adult | 9 | 2015 | 3557 | 0.250 |
Why?
|
| Dietary Fats | 2 | 2006 | 26 | 0.250 |
Why?
|
| Vitamin E | 3 | 2005 | 23 | 0.250 |
Why?
|
| Intelligence | 1 | 2006 | 10 | 0.250 |
Why?
|
| Neurotic Disorders | 2 | 2005 | 4 | 0.250 |
Why?
|
| Decision Support Techniques | 1 | 2006 | 24 | 0.240 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2016 | 82 | 0.240 |
Why?
|
| Logistic Models | 6 | 2017 | 196 | 0.240 |
Why?
|
| Smell | 2 | 2016 | 9 | 0.240 |
Why?
|
| Psychiatric Status Rating Scales | 7 | 2016 | 132 | 0.240 |
Why?
|
| tau Proteins | 5 | 2023 | 88 | 0.240 |
Why?
|
| Personality Disorders | 1 | 2006 | 7 | 0.240 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2017 | 40 | 0.240 |
Why?
|
| Child Abuse | 1 | 2006 | 9 | 0.240 |
Why?
|
| Awareness | 2 | 2016 | 21 | 0.240 |
Why?
|
| Risk Assessment | 9 | 2018 | 295 | 0.230 |
Why?
|
| Delusions | 1 | 2005 | 5 | 0.230 |
Why?
|
| Fish Products | 1 | 2005 | 2 | 0.230 |
Why?
|
| Fishes | 1 | 2005 | 2 | 0.230 |
Why?
|
| Hallucinations | 1 | 2005 | 19 | 0.230 |
Why?
|
| Life | 1 | 2005 | 2 | 0.230 |
Why?
|
| Diet Surveys | 2 | 2006 | 12 | 0.220 |
Why?
|
| Lipids | 1 | 2025 | 28 | 0.220 |
Why?
|
| Vehicle Emissions | 1 | 2024 | 5 | 0.220 |
Why?
|
| Environmental Exposure | 1 | 2024 | 14 | 0.220 |
Why?
|
| Air Pollutants | 1 | 2024 | 10 | 0.220 |
Why?
|
| Particulate Matter | 1 | 2024 | 13 | 0.220 |
Why?
|
| Air Pollution | 1 | 2024 | 13 | 0.220 |
Why?
|
| Comorbidity | 7 | 2018 | 209 | 0.210 |
Why?
|
| Gait Disorders, Neurologic | 5 | 2009 | 67 | 0.210 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2006 | 134 | 0.210 |
Why?
|
| Nutrition Disorders | 1 | 2003 | 3 | 0.200 |
Why?
|
| Life Change Events | 2 | 2014 | 21 | 0.200 |
Why?
|
| Linear Models | 8 | 2017 | 115 | 0.200 |
Why?
|
| Cerebral Infarction | 3 | 2015 | 63 | 0.200 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2016 | 110 | 0.190 |
Why?
|
| Models, Statistical | 4 | 2021 | 60 | 0.190 |
Why?
|
| Cause of Death | 2 | 2021 | 32 | 0.190 |
Why?
|
| Social Behavior | 4 | 2011 | 38 | 0.190 |
Why?
|
| Hypertension | 2 | 2022 | 85 | 0.190 |
Why?
|
| Carotenoids | 1 | 2002 | 7 | 0.180 |
Why?
|
| Vitamin A | 1 | 2002 | 5 | 0.180 |
Why?
|
| Crime Victims | 1 | 2022 | 16 | 0.180 |
Why?
|
| Self Stimulation | 1 | 2002 | 5 | 0.180 |
Why?
|
| Intermediate Filaments | 1 | 2022 | 5 | 0.180 |
Why?
|
| Mental Status Schedule | 6 | 2017 | 38 | 0.180 |
Why?
|
| Elder Abuse | 1 | 2022 | 19 | 0.180 |
Why?
|
| Metacognition | 1 | 2021 | 3 | 0.170 |
Why?
|
| Diabetes Complications | 2 | 2016 | 28 | 0.170 |
Why?
|
| Cerebrovascular Disorders | 2 | 2020 | 60 | 0.170 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2021 | 6 | 0.170 |
Why?
|
| Statistics, Nonparametric | 4 | 2015 | 72 | 0.170 |
Why?
|
| Residence Characteristics | 6 | 2015 | 87 | 0.170 |
Why?
|
| Cardiovascular Diseases | 2 | 2017 | 166 | 0.170 |
Why?
|
| Social Discrimination | 1 | 2021 | 5 | 0.170 |
Why?
|
| Serial Learning | 1 | 2020 | 4 | 0.160 |
Why?
|
| Memory and Learning Tests | 1 | 2020 | 5 | 0.160 |
Why?
|
| Epidemiologic Studies | 3 | 2012 | 14 | 0.160 |
Why?
|
| Music | 1 | 2021 | 11 | 0.160 |
Why?
|
| Prefrontal Cortex | 2 | 2019 | 66 | 0.160 |
Why?
|
| Health Status | 6 | 2019 | 96 | 0.160 |
Why?
|
| Musculoskeletal Diseases | 2 | 2010 | 19 | 0.160 |
Why?
|
| Brain Diseases | 1 | 2020 | 30 | 0.160 |
Why?
|
| Financial Management | 1 | 2020 | 6 | 0.160 |
Why?
|
| Frailty | 1 | 2020 | 6 | 0.160 |
Why?
|
| Health Equity | 1 | 2020 | 7 | 0.160 |
Why?
|
| Reproducibility of Results | 5 | 2012 | 324 | 0.150 |
Why?
|
| Space Perception | 1 | 2019 | 10 | 0.150 |
Why?
|
| Reference Values | 1 | 2020 | 103 | 0.150 |
Why?
|
| Child | 3 | 2013 | 614 | 0.150 |
Why?
|
| Neuropathology | 2 | 2017 | 42 | 0.150 |
Why?
|
| Neurocognitive Disorders | 1 | 2019 | 10 | 0.150 |
Why?
|
| Social Environment | 2 | 2012 | 38 | 0.150 |
Why?
|
| Neoplasms | 2 | 2018 | 94 | 0.150 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 20 | 0.140 |
Why?
|
| Neuroticism | 2 | 2016 | 13 | 0.140 |
Why?
|
| Blood Pressure | 3 | 2022 | 99 | 0.140 |
Why?
|
| Pain | 2 | 2010 | 193 | 0.140 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 4 | 0.140 |
Why?
|
| Emergencies | 1 | 2019 | 26 | 0.140 |
Why?
|
| Factor Analysis, Statistical | 2 | 2015 | 26 | 0.140 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 28 | 0.140 |
Why?
|
| Personality Inventory | 3 | 2009 | 31 | 0.140 |
Why?
|
| Economics | 1 | 2018 | 8 | 0.140 |
Why?
|
| Depressive Disorder | 1 | 2019 | 90 | 0.140 |
Why?
|
| Muscle Strength | 2 | 2009 | 46 | 0.130 |
Why?
|
| Osteoporosis | 1 | 2018 | 51 | 0.130 |
Why?
|
| Muscle Rigidity | 2 | 2008 | 5 | 0.130 |
Why?
|
| Gene Expression | 1 | 2018 | 97 | 0.130 |
Why?
|
| Predictive Value of Tests | 4 | 2018 | 218 | 0.130 |
Why?
|
| Urinary Incontinence | 1 | 2017 | 15 | 0.130 |
Why?
|
| Haplotypes | 1 | 2017 | 26 | 0.130 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 33 | 0.130 |
Why?
|
| Brazil | 3 | 2021 | 17 | 0.130 |
Why?
|
| Apolipoprotein E3 | 1 | 2017 | 8 | 0.130 |
Why?
|
| Homozygote | 1 | 2017 | 8 | 0.130 |
Why?
|
| Prognosis | 3 | 2018 | 363 | 0.120 |
Why?
|
| Genetic Variation | 1 | 2017 | 44 | 0.120 |
Why?
|
| Psychometrics | 5 | 2012 | 95 | 0.120 |
Why?
|
| Clergy | 5 | 2013 | 39 | 0.120 |
Why?
|
| Prejudice | 2 | 2008 | 21 | 0.120 |
Why?
|
| Biostatistics | 1 | 2016 | 3 | 0.120 |
Why?
|
| Brain Stem | 1 | 2016 | 7 | 0.120 |
Why?
|
| Employment | 1 | 2016 | 22 | 0.120 |
Why?
|
| Social Adjustment | 2 | 2006 | 11 | 0.120 |
Why?
|
| Copper | 2 | 2024 | 11 | 0.120 |
Why?
|
| Motor Disorders | 1 | 2015 | 13 | 0.110 |
Why?
|
| Odds Ratio | 4 | 2017 | 115 | 0.110 |
Why?
|
| Empathy | 1 | 2014 | 18 | 0.110 |
Why?
|
| Health Behavior | 2 | 2020 | 74 | 0.110 |
Why?
|
| Dancing | 1 | 2014 | 5 | 0.110 |
Why?
|
| Heterozygote | 3 | 2025 | 72 | 0.100 |
Why?
|
| Raphe Nuclei | 1 | 2013 | 5 | 0.100 |
Why?
|
| Locus Coeruleus | 1 | 2013 | 6 | 0.100 |
Why?
|
| Ventral Tegmental Area | 1 | 2013 | 7 | 0.100 |
Why?
|
| HIV Infections | 1 | 2017 | 256 | 0.100 |
Why?
|
| Cell Count | 1 | 2013 | 38 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2021 | 1467 | 0.100 |
Why?
|
| Smoking | 2 | 2012 | 84 | 0.100 |
Why?
|
| Health Promotion | 1 | 2014 | 78 | 0.100 |
Why?
|
| Income | 3 | 2020 | 35 | 0.100 |
Why?
|
| Cholinergic Antagonists | 1 | 2013 | 5 | 0.100 |
Why?
|
| Young Adult | 2 | 2013 | 863 | 0.100 |
Why?
|
| Adolescent | 2 | 2013 | 989 | 0.100 |
Why?
|
| Health Status Disparities | 1 | 2013 | 30 | 0.100 |
Why?
|
| Quality of Life | 1 | 2015 | 261 | 0.090 |
Why?
|
| Choice Behavior | 1 | 2012 | 19 | 0.090 |
Why?
|
| Child, Preschool | 1 | 2013 | 320 | 0.090 |
Why?
|
| Synapses | 1 | 2012 | 15 | 0.090 |
Why?
|
| Anomie | 1 | 2012 | 2 | 0.090 |
Why?
|
| Hydrocortisone | 1 | 2012 | 16 | 0.090 |
Why?
|
| Confidence Intervals | 5 | 2017 | 42 | 0.090 |
Why?
|
| Population Surveillance | 3 | 2015 | 46 | 0.090 |
Why?
|
| Statistics as Topic | 2 | 2017 | 51 | 0.090 |
Why?
|
| Patient Dropouts | 1 | 2012 | 18 | 0.090 |
Why?
|
| Bias | 1 | 2012 | 16 | 0.090 |
Why?
|
| Socioeconomic Factors | 4 | 2018 | 153 | 0.090 |
Why?
|
| Association | 1 | 2011 | 4 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 87 | 0.090 |
Why?
|
| Body Mass Index | 3 | 2023 | 221 | 0.090 |
Why?
|
| Guanylate Kinases | 1 | 2011 | 1 | 0.080 |
Why?
|
| Post-Synaptic Density | 1 | 2011 | 1 | 0.080 |
Why?
|
| Corticosterone | 1 | 2011 | 2 | 0.080 |
Why?
|
| Microfilament Proteins | 1 | 2011 | 15 | 0.080 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 9 | 0.080 |
Why?
|
| Receptors, Complement 3b | 1 | 2011 | 8 | 0.080 |
Why?
|
| Visual Perception | 1 | 2011 | 14 | 0.080 |
Why?
|
| Community Health Planning | 1 | 2011 | 7 | 0.080 |
Why?
|
| Illinois | 3 | 2017 | 110 | 0.080 |
Why?
|
| Wechsler Scales | 2 | 2010 | 5 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 46 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2011 | 69 | 0.080 |
Why?
|
| Genetic Association Studies | 3 | 2017 | 45 | 0.080 |
Why?
|
| Interviews as Topic | 2 | 2021 | 66 | 0.080 |
Why?
|
| Diet, Mediterranean | 1 | 2010 | 27 | 0.080 |
Why?
|
| Self Care | 1 | 2010 | 53 | 0.080 |
Why?
|
| Prevalence | 2 | 2021 | 175 | 0.070 |
Why?
|
| Somatosensory Disorders | 1 | 2009 | 5 | 0.070 |
Why?
|
| Hostility | 1 | 2009 | 9 | 0.070 |
Why?
|
| Sensory Thresholds | 1 | 2009 | 13 | 0.070 |
Why?
|
| Vibration | 1 | 2009 | 18 | 0.070 |
Why?
|
| Movement Disorders | 1 | 2009 | 32 | 0.070 |
Why?
|
| Self Report | 2 | 2022 | 94 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2008 | 14 | 0.070 |
Why?
|
| Sex Characteristics | 2 | 2022 | 64 | 0.070 |
Why?
|
| Psychological Tests | 2 | 2013 | 20 | 0.070 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2005 | 9 | 0.070 |
Why?
|
| Differential Threshold | 1 | 2008 | 2 | 0.070 |
Why?
|
| Hypokinesia | 1 | 2008 | 8 | 0.070 |
Why?
|
| Tremor | 1 | 2008 | 60 | 0.070 |
Why?
|
| Hand Strength | 1 | 2007 | 24 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 464 | 0.070 |
Why?
|
| Leg | 1 | 2007 | 16 | 0.060 |
Why?
|
| Personal Space | 1 | 2007 | 4 | 0.060 |
Why?
|
| Latin America | 1 | 2006 | 1 | 0.060 |
Why?
|
| Dyskinesias | 1 | 2006 | 5 | 0.060 |
Why?
|
| Likelihood Functions | 2 | 2017 | 12 | 0.060 |
Why?
|
| Trans Fatty Acids | 1 | 2006 | 4 | 0.060 |
Why?
|
| Ambulatory Care Facilities | 1 | 2006 | 23 | 0.060 |
Why?
|
| Medicare | 2 | 2019 | 59 | 0.060 |
Why?
|
| Fatty Acids | 1 | 2006 | 20 | 0.060 |
Why?
|
| Psychology | 1 | 2006 | 13 | 0.060 |
Why?
|
| Parent-Child Relations | 1 | 2006 | 15 | 0.060 |
Why?
|
| Population Groups | 1 | 2005 | 3 | 0.060 |
Why?
|
| Parenting | 1 | 2006 | 37 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2006 | 116 | 0.060 |
Why?
|
| Genome-Wide Association Study | 2 | 2016 | 108 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2006 | 68 | 0.060 |
Why?
|
| Energy Intake | 1 | 2005 | 46 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2005 | 99 | 0.060 |
Why?
|
| Eating | 1 | 2005 | 25 | 0.060 |
Why?
|
| Attention | 1 | 2005 | 46 | 0.060 |
Why?
|
| Parents | 1 | 2006 | 51 | 0.060 |
Why?
|
| Family Characteristics | 1 | 2005 | 11 | 0.060 |
Why?
|
| Tocopherols | 1 | 2005 | 4 | 0.060 |
Why?
|
| Triglycerides | 1 | 2025 | 24 | 0.060 |
Why?
|
| Sleep | 1 | 2006 | 155 | 0.060 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 4 | 0.050 |
Why?
|
| Nitrogen Oxides | 1 | 2024 | 4 | 0.050 |
Why?
|
| Cholesterol | 1 | 2025 | 30 | 0.050 |
Why?
|
| Animals | 2 | 2011 | 2092 | 0.050 |
Why?
|
| Zinc | 1 | 2024 | 21 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 171 | 0.050 |
Why?
|
| Gait | 3 | 2014 | 195 | 0.050 |
Why?
|
| Markov Chains | 2 | 2015 | 15 | 0.050 |
Why?
|
| Seafood | 1 | 2003 | 7 | 0.050 |
Why?
|
| Fraud | 1 | 2022 | 6 | 0.050 |
Why?
|
| Executive Function | 1 | 2021 | 47 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2021 | 24 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2013 | 105 | 0.040 |
Why?
|
| Mathematics | 1 | 2021 | 25 | 0.040 |
Why?
|
| Writing | 1 | 2021 | 10 | 0.040 |
Why?
|
| Catholicism | 2 | 2013 | 7 | 0.040 |
Why?
|
| Attitude to Death | 1 | 2020 | 5 | 0.040 |
Why?
|
| Tissue and Organ Procurement | 1 | 2020 | 22 | 0.040 |
Why?
|
| Postural Balance | 2 | 2014 | 62 | 0.040 |
Why?
|
| Focus Groups | 1 | 2020 | 50 | 0.040 |
Why?
|
| Minority Groups | 1 | 2020 | 40 | 0.040 |
Why?
|
| Intelligence Tests | 2 | 2014 | 9 | 0.040 |
Why?
|
| Nutrition Assessment | 3 | 2005 | 19 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 252 | 0.040 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2019 | 14 | 0.040 |
Why?
|
| Proteomics | 1 | 2019 | 39 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2018 | 166 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 71 | 0.030 |
Why?
|
| Dementia, Vascular | 1 | 2018 | 19 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2017 | 13 | 0.030 |
Why?
|
| Diagnosis | 1 | 2017 | 8 | 0.030 |
Why?
|
| Sex Distribution | 2 | 2009 | 34 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 6 | 0.030 |
Why?
|
| Tuberous Sclerosis | 1 | 2017 | 11 | 0.030 |
Why?
|
| Inflammation | 1 | 2018 | 124 | 0.030 |
Why?
|
| Arteriolosclerosis | 1 | 2016 | 25 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 20 | 0.030 |
Why?
|
| Brain Infarction | 1 | 2016 | 36 | 0.030 |
Why?
|
| Anisotropy | 1 | 2016 | 25 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2016 | 26 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2016 | 40 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 73 | 0.030 |
Why?
|
| Demography | 1 | 2016 | 37 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 90 | 0.030 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2015 | 4 | 0.030 |
Why?
|
| Mental Health | 1 | 2016 | 47 | 0.030 |
Why?
|
| Personality Assessment | 2 | 2006 | 15 | 0.030 |
Why?
|
| Self Efficacy | 1 | 2014 | 30 | 0.030 |
Why?
|
| Interview, Psychological | 1 | 2014 | 17 | 0.030 |
Why?
|
| Dietary Supplements | 2 | 2005 | 26 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2014 | 156 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 84 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2012 | 8 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 14 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2012 | 7 | 0.020 |
Why?
|
| Multilevel Analysis | 1 | 2012 | 4 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2012 | 30 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2012 | 20 | 0.020 |
Why?
|
| Disks Large Homolog 4 Protein | 1 | 2011 | 3 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 62 | 0.020 |
Why?
|
| Nutrition Policy | 1 | 2010 | 7 | 0.020 |
Why?
|
| Trail Making Test | 1 | 2010 | 3 | 0.020 |
Why?
|
| Wine | 1 | 2010 | 6 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 125 | 0.020 |
Why?
|
| Epidemiologic Research Design | 1 | 2010 | 12 | 0.020 |
Why?
|
| Health Surveys | 1 | 2011 | 38 | 0.020 |
Why?
|
| Amyloid | 1 | 2010 | 20 | 0.020 |
Why?
|
| Internet | 1 | 2011 | 30 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 205 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2010 | 75 | 0.020 |
Why?
|
| Algorithms | 1 | 2011 | 169 | 0.020 |
Why?
|
| Mechanoreceptors | 1 | 2009 | 5 | 0.020 |
Why?
|
| Proprioception | 1 | 2009 | 8 | 0.020 |
Why?
|
| Age Distribution | 1 | 2009 | 25 | 0.020 |
Why?
|
| Joints | 1 | 2009 | 43 | 0.020 |
Why?
|
| Mice | 1 | 2011 | 760 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 201 | 0.020 |
Why?
|
| Observation | 1 | 2007 | 5 | 0.020 |
Why?
|
| Muscle Strength Dynamometer | 1 | 2007 | 6 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2007 | 22 | 0.020 |
Why?
|
| Heart Failure | 1 | 2007 | 77 | 0.010 |
Why?
|
| Verbal Behavior | 1 | 2005 | 6 | 0.010 |
Why?
|
| Pattern Recognition, Visual | 1 | 2005 | 4 | 0.010 |
Why?
|
| Photic Stimulation | 1 | 2005 | 11 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 15 | 0.010 |
Why?
|
| Cultural Diversity | 1 | 2005 | 16 | 0.010 |
Why?
|
| Community Mental Health Centers | 1 | 2005 | 3 | 0.010 |
Why?
|
| alpha-Tocopherol | 1 | 2005 | 7 | 0.010 |
Why?
|
| gamma-Tocopherol | 1 | 2005 | 7 | 0.010 |
Why?
|
| Sick Role | 1 | 2004 | 5 | 0.010 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2003 | 4 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2003 | 6 | 0.010 |
Why?
|
| Docosahexaenoic Acids | 1 | 2003 | 6 | 0.010 |
Why?
|
| beta Carotene | 1 | 2002 | 5 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2002 | 23 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 2002 | 25 | 0.010 |
Why?
|
| Hypotension | 1 | 2002 | 11 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2002 | 53 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2002 | 141 | 0.010 |
Why?
|